ErbB2 induces malignant transformation and tumorigenesis in NIH 3T3 fibroblasts, indicating that ErbB2 functions as an oncogene that is also correlated with a poor prognosis in malignancy, e.g., in sarcoma [30, 31]. This evidence concerns the gene ERBB2 and sarcoma.